Biography

Fangyu Peng, M.D., Ph.D., is a physician-scientist who practices clinical nuclear medicine, with research interest in PET translational imaging and cancer therapy.

Dr. Peng is conducting translational research of inherited and acquired copper metabolism disorders in Wilson's disease, Alzheimer's disease, and traumatic brain injury.

Dr. Peng is studying copper metabolism as a theranostic target for molecular imaging and cancer therapy.

Education

Medical School Jiangxi Medical College (1982)
Graduate School University of South Florida Program (1994), Nuclear Medicine
Fellowship Ball Memorial Hospital (1996), Hematopathology
Residency SUNY Upstate Medical University (1998), Pathology
Residency University of Connecticut Health Center (2000), Nuclear Medicine
Residency Hartford Hospital (2002), Anatomic Pathology
Fellowship Warren Grant Magnuson Clinical Center - NIH (2003), Nuclear Medicine

Specialty Areas

Research Interest

  • Metabolic imaging of copper metabolism imbalance in Wilson's disease, Alzheimer's disease, and traumatic brain injury
  • Molecular imaging and cancer therapy targeting copper metabolism and circulating tumor cells

Publications

Featured Publications LegendFeatured Publications

Detection of Widespread Metastasis in a Case of Aggressive Carcinoma Showing Thymuslike Differentiation (CASTLE Disease) Using 18F-FDG PET/CT.
Iyamu I, Wachsmann J, Truelson J, Mathews D, Peng F Clin Nucl Med 2015 Apr
Synthesis and Characterization of Her2-NLP Peptide Conjugates Targeting Circulating Breast Cancer Cells: Cellular Uptake and Localization by Fluorescent Microscopic Imaging.
Cai H, Singh AN, Sun X, Peng F J Fluoresc 2015 Jan
Reduced 64Cu Uptake and Tumor Growth Inhibition by Knockdown of Human Copper Transporter 1 in Xenograft Mouse Model of Prostate Cancer.
Cai H, Wu JS, Muzik O, Hsieh JT, Lee RJ, Peng F J. Nucl. Med. 2014 Mar
2-NBDG Fluorescence Imaging of Hypermetabolic Circulating Tumor Cells in Mouse Xenograft model of Breast Cancer.
Cai H, Peng F J Fluoresc 2013 Jan 23 1 213-20
Synthesis and Characterization of Theranostic Poly(HPMA)-c(RGDyK)-DOTA-64Cu Copolymer Targeting Tumor Angiogenesis: Tumor Localization Visualized by Positron Emission Tomography.
Yuan J, Zhang H, Kaur H, Oupicky D, Peng F Mol Imaging 2012 May 12 3 203-12
Positron emission tomography of copper metabolism in the Atp7b?/? knock-out mouse model of Wilson's disease.
Peng F, Lutsenko S, Sun X, Muzik O Mol Imaging Biol 2012 Feb 14 1 70-8
Positron Emission Tomography of Human Hepatocellular Carcinoma Xenografts in Mice Using Copper (II)-64 Chloride as a Tracer with Copper (II)-64 Chloride.
Zhang H, Cai H, Lu X, Muzik O, Peng F Acad Radiol 2011 Dec 18 12 1561-8
Imaging Copper Metabolism Imbalance in Atp7b (-/-) Knockout Mouse Model of Wilson's Disease with PET-CT and Orally Administered (64)CuCl (2).
Peng F, Lutsenko S, Sun X, Muzik O Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2011 Dec

Professional Associations/Affiliations

  • American College of Nuclear Medicine (2014)
  • Society of Nuclear Medicine and Molecular Imaging (1998)